OraSure Technologies | OSUR - Ebitda


OraSure Technologies reported $-17.7M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
AngioDynamics USD 5.94M 3.78M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio Techne USD 116.71M 13.29M Mar/2026
Bio-Rad Laboratories USD 983.8M 1.36B Dec/2025
Bruker USD 110M 101.6M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Illumina USD 469M 137M Dec/2025
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 108.7M 44.6M Mar/2026
Repligen USD 40.01M 469K Mar/2026
Revvity USD 272.91M 24M Mar/2026
STAAR Surgical USD -159K 34.78M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Trinity Biotech USD -9.6M 7.64M Dec/2024
Waters USD 380.97M 85.83M Dec/2025